BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29891724)

  • 21. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reaction.
    Greenberg R; Schwartz I; Skornick Y; Kaplan O
    Breast Cancer Res; 2003; 5(3):R71-6. PubMed ID: 12793903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.
    Kohrt HE; Nouri N; Nowels K; Johnson D; Holmes S; Lee PP
    PLoS Med; 2005 Sep; 2(9):e284. PubMed ID: 16124834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
    Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
    Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
    Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
    Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does ultrasound evaluation of the axilla increase the rate of axillary lymph node dissection in early stage clinically node negative breast cancer patients?
    Vasigh M; Meshkati Yazd SM; Karoobi M; Hajebi R; Yazdankhah Kenari A
    BMC Surg; 2022 Mar; 22(1):80. PubMed ID: 35241059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
    Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
    BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
    Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG
    Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
    Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
    Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer.
    Zhang X; Zhao W; Wei W; You Z; Ou X; Sun M; Yin Y; Tang X; Zhao Z; Hu C; Liu F; Deng J; Mao L; Zhou D; Ren Y; Li X; Zhang S; Liu C; Geng J; Yao G; Song B; Liu Y; Li D; Jiang Y; Chen Y; Zhao Y; Yu S; Pang D
    Clin Cancer Res; 2019 Nov; 25(21):6546-6553. PubMed ID: 31350313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer.
    Kang HS; Youn YK; Oh SK; Choe KJ; Noh DY
    Breast Cancer Res Treat; 2000 Sep; 63(1):81-7. PubMed ID: 11079162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.
    Venet D; Fimereli D; Rothé F; Boeckx B; Maetens M; Majjaj S; Rouas G; Capra M; Bonizzi G; Contaldo F; Galant C; Piccart M; Pruneri G; Larsimont D; Lambrechts D; Desmedt C; Sotiriou C
    EBioMedicine; 2020 Jun; 56():102793. PubMed ID: 32512508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.
    Schneider J; Gonzalez-Roces S; Pollán M; Lucas R; Tejerina A; Martin M; Alba A
    Breast Cancer Res; 2001; 3(3):183-91. PubMed ID: 11305953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.
    Newman EA; Sabel MS; Nees AV; Schott A; Diehl KM; Cimmino VM; Chang AE; Kleer C; Hayes DF; Newman LA
    Ann Surg Oncol; 2007 Oct; 14(10):2946-52. PubMed ID: 17514407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750).
    Skarping I; Ellbrant J; Dihge L; Ohlsson M; Huss L; Bendahl PO; Rydén L
    BMC Cancer; 2024 Jan; 24(1):86. PubMed ID: 38229058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.